Literature DB >> 788992

Nortriptyline plasma levels and therapeutic response.

V E Ziegler, P J Clayton, J R Taylor, B Tee, J T Biggs.   

Abstract

Eighteen depressed outpatients were treated for 6 wk with a mean daily dose of 121 mg of nortriptyline. The mean plasma level was 138 ng/ml during treatment. Therapeutic response was monitored by the Zung Self-Rating Depression Scale and the Hamilton Depression Scale administrered by two psychiatrists blind to the tricyclic used, dose, and plasma levels. Eight patients recovered (Hamilton less than or equal to 6) by the fourth week and 12 by the sixth week. During the steady-state (wk 4 to 6) there was a positive correlation between the weekly Hamilton scores and the weekly nortriptyline levels (p less than 0.01). The 9 patients with mean plasma levels between 50 and 139 ng/ml had a better therapeutic response after 6 wk measured by percent recovered (p less than 0.005). Zung score (p less than 0.05), and Hamilton score (p less than 0.025) than the 9 patients with mean plasma levels between 140 and 260 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 788992     DOI: 10.1002/cpt1976204458

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  24 in total

Review 1.  Therapeutic drug monitoring of psychotropic medications.

Authors:  P B Mitchell
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

2.  Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response.

Authors:  M Jerling
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

3.  Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolites.

Authors:  R Malmgren; A Aberg-Wistedt; L Bertilsson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.

Authors:  S Vandel; B Vandel; M Sandoz; G Allers; P Bechtel; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

Review 5.  Plasma level monitoring of tricyclic antidepressant therapy.

Authors:  L F Gram
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

6.  Antidepressants in the general hospital.

Authors:  A J Gelenberg
Journal:  Can Med Assoc J       Date:  1979-06-09       Impact factor: 8.262

7.  Imipramine: clinical effects and pharmacokinetic variability.

Authors:  N Reisby; L F Gram; P Bech; A Nagy; G O Petersen; J Ortmann; I Ibsen; S J Dencker; O Jacobsen; O Krautwald; I Sondergaard; J Christiansen
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

8.  The pharmacokinetics of nortriptyline in patients with chronic renal failure.

Authors:  S Dawlilng; K Lynn; R Rosser; R Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

9.  Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night-time and divided daily dose regimens.

Authors:  S Montgomery; R McAuley; D B Montgomery
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

10.  Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.

Authors:  B Vandel; S Vandel; J M Jounet; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.